Published in Arch Ophthalmol on November 01, 1999
Initial Versus Delayed PDT Combination With Conbercept in PCV | NCT02821520
Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol (2011) 1.83
Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study. Br J Ophthalmol (2002) 1.54
Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy. Br J Ophthalmol (2004) 1.52
The origins of polypoidal choroidal vasculopathy. Br J Ophthalmol (2005) 1.44
Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population. Nat Genet (2011) 1.43
EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy. Br J Ophthalmol (2015) 1.39
Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy. Ophthalmology (2010) 1.38
Polypoidal choroidal vasculopathy in Chinese patients. Br J Ophthalmol (2002) 1.28
Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation. Br J Ophthalmol (2002) 1.28
The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy. Korean J Ophthalmol (2008) 1.25
Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients. Jpn J Ophthalmol (2008) 1.20
Polypoidal choroidal vasculopathy in elderly Chinese patients. Graefes Arch Clin Exp Ophthalmol (2004) 1.16
Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy. Jpn J Ophthalmol (2011) 1.14
Coding variant Met72Thr in the PEDF gene and risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Mol Vis (2009) 1.04
Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiography. Br J Ophthalmol (2007) 1.03
En face imaging of the choroid in polypoidal choroidal vasculopathy using swept-source optical coherence tomography. Am J Ophthalmol (2014) 1.00
Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography. Graefes Arch Clin Exp Ophthalmol (2007) 0.97
Ocular perfusion pressure and choroidal thickness in eyes with polypoidal choroidal vasculopathy, wet-age-related macular degeneration, and normals. Eye (Lond) (2013) 0.92
Analysis of candidate genes for age-related macular degeneration subtypes in the Japanese population. Mol Vis (2011) 0.91
Genetic and functional dissection of ARMS2 in age-related macular degeneration and polypoidal choroidal vasculopathy. PLoS One (2013) 0.90
Short-term efficacy of intravitreal aflibercept for patients with treatment-naïve polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol (2014) 0.88
Polypoidal choroidal vasculopathy in a patient with angioid streaks secondary to pseudoxanthoma elasticum. Graefes Arch Clin Exp Ophthalmol (2010) 0.88
Polypoidal choroidal vasculopathy and retinochoroidal anastomosis in Japanese patients eligible for photodynamic therapy for exudative age-related macular degeneration. Jpn J Ophthalmol (2006) 0.88
Haplotype analysis of the ARMS2/HTRA1 region in Japanese patients with typical neovascular age-related macular degeneration or polypoidal choroidal vasculopathy. Jpn J Ophthalmol (2010) 0.87
SERPING1 polymorphisms in polypoidal choroidal vasculopathy. Mol Vis (2010) 0.86
Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy. Eye (Lond) (2014) 0.85
Polypoidal Choroidal Vasculopathy in Asians. J Clin Med (2015) 0.84
Association of clinical characteristics with disease subtypes, initial visual acuity, and visual prognosis in neovascular age-related macular degeneration. Jpn J Ophthalmol (2009) 0.84
Photodynamic therapy for polypoidal choroidal vasculopathy: vaso-occlusive effect on the branching vascular network and origin of recurrence. Jpn J Ophthalmol (2008) 0.82
The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients. Graefes Arch Clin Exp Ophthalmol (2015) 0.82
Early signs of exudative age-related macular degeneration in Asians. Optom Vis Sci (2014) 0.82
Development of polypoidal lesions in age-related macular degeneration. Eye (Lond) (2011) 0.81
Resolution of persistent pigment epithelial detachment secondary to polypoidal choroidal vasculopathy in response to Aflibercept. Eye (Lond) (2014) 0.81
Five-year results of photodynamic therapy with verteporfin for Japanese patients with neovascular age-related macular degeneration. Clin Ophthalmol (2013) 0.80
Combined photodynamic therapy and intravitreal bevacizumab for idiopathic polypoidal choroidal vasculopathy: one-year follow-up. Clin Ophthalmol (2010) 0.80
Characteristics of fundus autofluorescence and drusen in the fellow eyes of Japanese patients with exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2013) 0.80
Ranibizumab for the treatment of degenerative ocular conditions. Clin Ophthalmol (2014) 0.80
Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol (2015) 0.80
COL1A2 polymorphic markers confer an increased risk of neovascular age-related macular degeneration in a Han Chinese population. Mol Vis (2012) 0.80
Positive association of CD36 gene variants with the visual outcome of photodynamic therapy in polypoidal choroidal vasculopathy. Mol Vis (2012) 0.80
EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study. Graefes Arch Clin Exp Ophthalmol (2016) 0.80
Comparison of initial treatment between 3-monthly intravitreal aflibercept monotherapy and combined photodynamic therapy with single intravitreal aflibercept for polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol (2016) 0.80
Characteristics of age-related macular degeneration in patients with diabetic retinopathy. Jpn J Ophthalmol (2011) 0.79
Classic choroidal neovascularization developing after photodynamic therapy in eyes with polypoidal choroidal vasculopathy. Jpn J Ophthalmol (2011) 0.78
Spectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth pattern. Clin Ophthalmol (2014) 0.78
Photodynamic therapy alone versus combined with intravitreal bevacizumab for neovascular age-related macular degeneration without polypoidal choroidal vasculopathy in Japanese patients. Graefes Arch Clin Exp Ophthalmol (2010) 0.78
Factors associated with polyp regression after intravitreal ranibizumab injections for polypoidal choroidal vasculopathy. Jpn J Ophthalmol (2014) 0.77
Time-lag between subretinal fluid and pigment epithelial detachment reduction after polypoidal choroidal vasculopathy treatment. Korean J Ophthalmol (2011) 0.77
Thickness of photoreceptor layers in polypoidal choroidal vasculopathy and central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol (2010) 0.77
Polypoidal choroidal vasculopathy coexisting with exudative age-related macular degeneration. Int Ophthalmol (2007) 0.77
Baseline polyp size as a potential predictive factor for recurrence of polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol (2015) 0.77
Determinants of patient satisfaction with photodynamic therapy for neovascular age-related macular degeneration or polypoidal choroidal vasculopathy. Jpn J Ophthalmol (2007) 0.77
Plasticity of polypoidal lesions in polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol (2004) 0.76
Hyperhomocysteinemia in patients with polypoidal choroidal vasculopathy: a case control study. PLoS One (2014) 0.76
HTRA1 promoter variant differentiates polypoidal choroidal vasculopathy from exudative age-related macular degeneration. Sci Rep (2016) 0.75
Polypoidal choroidal vasculopathy with an appearance similar to classic choroidal neovascularisation on fluorescein angiography. Br J Ophthalmol (2007) 0.75
Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy. Eye (Lond) (2016) 0.75
Systemic steroids as an aid to the management of Idiopathic Polypoidal Choroidal Vasculopathy (IPCV): A descriptive analysis. Saudi J Ophthalmol (2015) 0.75
Analysis of the Serum Lipid Profile in Polypoidal Choroidal Vasculopathy. Sci Rep (2016) 0.75
Evidence of a novel gene HERPUD1 in polypoidal choroidal vasculopathy. Int J Clin Exp Pathol (2015) 0.75
Practicability confirmation by meta-analysis of intravitreal ranibizumab compared to photodynamic therapy to treat polypoidal choroidal vasculopathy. Mol Vis (2015) 0.75
Characteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom. Int J Retina Vitreous (2017) 0.75
Two-year outcomes of pro re nata ranibizumab monotherapy for exudative age-related macular degeneration in Japanese patients. Clin Ophthalmol (2013) 0.75
High-dose ranibizumab monotherapy for neovascular polypoidal choroidal vasculopathy in a predominantly non-Asian population. Eye (Lond) (2015) 0.75
Idiopathic polypoidal choroidal vasculopathy in Thai patients with clinical and angiographic choroidal neovascularization. Clin Ophthalmol (2017) 0.75
Polypoidal choroidal vasculopathy. Br J Ophthalmol (2007) 0.75
The association of elastin gene variants with two angiographic subtypes of polypoidal choroidal vasculopathy. PLoS One (2015) 0.75
Combined argon laser photocoagulation and antivascular endothelial growth factor for management of macular polypoidal choroidal vasculopathy. Oman J Ophthalmol (2016) 0.75
Reduced-fluence photodynamic therapy and anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy in an Indian population. Indian J Ophthalmol (2016) 0.75
Effects of three consecutive monthly intravitreal injection of ranibizumab for polypoidal choroidal vasculopathy in Korea. Int J Ophthalmol (2015) 0.75
Transitions of multifocal electroretinography following combined intravitreal bevacizumab and photodynamic therapy for polypoidal choroidal vasculopathy. Doc Ophthalmol (2009) 0.75
A genome-wide association study identified a novel genetic loci STON1-GTF2A1L/LHCGR/FSHR for bilaterality of neovascular age-related macular degeneration. Sci Rep (2017) 0.75
Asymptomatic extramacular abnormal choroidal lesions in eyes with macular polypoidal choroidal vasculopathy. Jpn J Ophthalmol (2010) 0.75
Neovascularization associated with large retinal pigment epithelial detachment in elderly Korean patients: subdivision according to indocyanine green angiographic features. Jpn J Ophthalmol (2007) 0.75
Functional connectivity in single and multislice echoplanar imaging using resting-state fluctuations. Neuroimage (1998) 12.43
Locating blood vessels in retinal images by piecewise threshold probing of a matched filter response. IEEE Trans Med Imaging (2000) 4.57
Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina (1990) 4.46
Retinal angiomatous proliferation in age-related macular degeneration. Retina (2001) 4.04
Detection of blood vessels in retinal images using two-dimensional matched filters. IEEE Trans Med Imaging (1989) 3.76
Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol (1994) 3.44
Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol (1999) 3.13
Penetrating ocular fish-hook injuries. Surgical management and long-term visual outcome. Ophthalmology (1992) 2.96
The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol (1997) 2.93
Digital indocyanine green videoangiography and choroidal neovascularization. Retina (1992) 2.86
External beam radiation therapy for choroidal neovascularization. Ophthalmology (1998) 2.84
Interferon-associated retinopathy. Arch Ophthalmol (1993) 2.73
Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina (1995) 2.65
Adverse reactions due to indocyanine green. Ophthalmology (1994) 2.30
Central serous chorioretinopathy in younger and older adults. Ophthalmology (1996) 2.26
Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology (2000) 2.09
Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology (2006) 2.04
Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial. Br J Ophthalmol (2008) 2.03
Precision and accuracy of bone mineral determination by direct photon absorptiometry. Invest Radiol (1968) 1.86
Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology (2006) 1.80
Ophthalmic manifestations of leukemia. Arch Ophthalmol (1989) 1.75
Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina (1996) 1.65
Correlation of transient vision loss with outer retinal disruption following intravitreal ocriplasmin. Eye (Lond) (2013) 1.64
The ocular complications of boxing. Ophthalmology (1987) 1.60
An examination of race and poverty for populations living near industrial sources of air pollution. J Expo Anal Environ Epidemiol (1999) 1.58
Proliferative retinopathy in sickle cell trait. Report of seven cases. Arch Intern Med (1977) 1.56
Measurement and classification of retinal vascular tortuosity. Int J Med Inform (1999) 1.56
Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology (2000) 1.55
Unilateral acute idiopathic maculopathy. Arch Ophthalmol (1991) 1.53
Regional and postnatal heterogeneity of activity-dependent long-term changes in synaptic efficacy in the dorsal striatum. J Neurophysiol (2000) 1.51
The expanding clinical spectrum of unilateral acute idiopathic maculopathy. Arch Ophthalmol (1996) 1.48
Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck (1997) 1.48
Macular and perimacular vascular remodelling sickling haemoglobinopathies. Br J Ophthalmol (1976) 1.48
Idiopathic polypoidal choroidal vasculopathy of the macula. Ophthalmology (1998) 1.46
Involving the general public in priority setting: experiences from Australia. Soc Sci Med (2003) 1.46
Varicella-zoster virus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol (1991) 1.46
Indocyanine green-guided laser photocoagulation of focal spots at the edge of plaques of choroidal neovascularization. Arch Ophthalmol (1996) 1.44
Developmental schedule of the postnatal rat testis determined by flow cytometry. Biol Reprod (1998) 1.44
Effects of meal size and correction technique on gastric emptying time: studies with two tracers and opposed detectors. J Nucl Med (1980) 1.38
Subfoveal choroidal neovascular membranes in age-related macular degeneration. Visual prognosis in eyes with relatively good initial visual acuity. Arch Ophthalmol (1986) 1.35
Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol (1993) 1.35
Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy. Eye (Lond) (2006) 1.30
Analysis of vascularized pigment epithelial detachments using indocyanine green videoangiography. Retina (1994) 1.25
Technical factors in gastric emptying studies. J Nucl Med (1983) 1.24
Localized 2D J-resolved 1H MR spectroscopy: strong coupling effects in vitro and in vivo. Magn Reson Imaging (1995) 1.23
Off-resonance spin locking for MR imaging. Magn Reson Med (1994) 1.23
Spatially filtering functional magnetic resonance imaging data. Magn Reson Med (1997) 1.20
The risk of cerebrovascular and cardiovascular disease in patients with anterior ischemic optic neuropathy. Arch Ophthalmol (1985) 1.20
Subretinal exudative deposits in central serous chorioretinopathy. Br J Ophthalmol (1993) 1.19
Macular hole. Surv Ophthalmol (1998) 1.19
Dislocation of the crystalline lens in a patient with Sturge-Weber syndrome. Ann Ophthalmol (1992) 1.18
Solar retinopathy. A photobiologic and geophysical analysis. Retina (1989) 1.17
Idiopathic polypoidal choroidal vasculopathy: a peripheral lesion. Arch Ophthalmol (1998) 1.17
Improvement in visual function after displacement of the retinal elevations emanating from optic pits. Arch Ophthalmol (1993) 1.13
Motorcycle ownership and injury in China. Inj Control Saf Promot (2004) 1.13
Factor V Leiden, activated protein C resistance, and retinal vein occlusion. Retina (1998) 1.13
Specific and potent inhibition of spermidine synthase by the transition-state analog, S-adenosyl-3-thio-1,8-diaminooctane. Biochem Biophys Res Commun (1980) 1.13
Scatter rejection by air gaps: an empirical model. Med Phys (1985) 1.11